Azitra (AZTR) Receivables - Net (2022 - 2026)
Azitra (AZTR) posted Receivables - Net of $5108.0 for Q1 2026, up 460.09% on a QoQ basis from $912.0 in Q4 2025.
Azitra (AZTR) Receivables - Net (2022 - 2026) Analysis & Trends
Azitra's Receivables - Net history runs 5 years deep, the most recent figure standing at $5108.0 for Q1 2026.
- Quarterly Receivables - Net changed N/A year-over-year to $5108.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5108.0 (changed N/A YoY) and the FY2025 annual result came in at $912.0, up 291.42% from the prior year.
- Receivables - Net was $5108.0 for Q1 2026 at Azitra, up from $912.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $445120.0 in Q2 2023 and bottomed at $233.0 in Q4 2024.
- A 5-year average of $79701.2 and a median of $3482.5 in 2024 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2024 — Receivables - Net tumbled 99.75% — and 2025, when it soared 291.42%.
- Azitra's Receivables - Net stood at $175000.0 in 2022, then slumped by 95.28% to $8255.0 in 2023, then slumped by 97.18% to $233.0 in 2024, then surged by 291.42% to $912.0 in 2025, then jumped by 460.09% to $5108.0 in 2026.
- Business Quant data shows AZTR's Receivables - Net at $5108.0 in Q1 2026, $912.0 in Q4 2025, and $233.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,108.00 |
| Mar 31, 2026 | 5,108.00 |
| Dec 31, 2025 | 912.00 |
| Dec 31, 2025 | 912.00 |
| Dec 31, 2024 | 233.00 |
| Dec 31, 2024 | 233.00 |
| Jun 30, 2024 | 1,125.00 |
| Jun 30, 2024 | 1,125.00 |
| Mar 31, 2024 | 1,857.00 |
| Mar 31, 2024 | 1,857.00 |
| Dec 31, 2023 | 8,255.00 |
| Dec 31, 2023 | 8,255.00 |
| Jun 30, 2023 | 445,120.00 |
| Jun 30, 2023 | 445,120.00 |
| Dec 31, 2022 | 175,000.00 |
| Dec 31, 2022 | 175,000.00 |